Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 389 entries
Sorted by: Best Match Show Resources per page
Circulating micrornas associated with glycemic impairment and progression in Asian Indians.

Biomarker research

Flowers E, Gadgil M, Aouizerat BE, Kanaya AM.
PMID: 26966540
Biomark Res. 2015 Oct 13;3:22. doi: 10.1186/s40364-015-0047-y. eCollection 2015.

AIMS/HYPOTHESIS: Asian Indians have a high incidence of type 2 diabetes, but factors associated with glycemic progression in this population are not understood. MicroRNAs are emerging as important mediators of glucose homeostasis and have not been previously studied in...

Cite
Flowers E, Gadgil M, Aouizerat BE, et al. Circulating micrornas associated with glycemic impairment and progression in Asian Indians. Biomark Res. 2015;3:22doi: 10.1186/s40364-015-0047-y.
Flowers, E., Gadgil, M., Aouizerat, B. E., & Kanaya, A. M. (2015). Circulating micrornas associated with glycemic impairment and progression in Asian Indians. Biomarker research, 322. https://doi.org/10.1186/s40364-015-0047-y
Flowers, Elena, et al. "Circulating micrornas associated with glycemic impairment and progression in Asian Indians." Biomarker research vol. 3 (2015): 22. doi: https://doi.org/10.1186/s40364-015-0047-y
Flowers E, Gadgil M, Aouizerat BE, Kanaya AM. Circulating micrornas associated with glycemic impairment and progression in Asian Indians. Biomark Res. 2015 Oct 13;3:22. doi: 10.1186/s40364-015-0047-y. eCollection 2015. PMID: 26966540; PMCID: PMC4785747.
Copy Download .nbib Format: NLM
Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia.

Biomarker research

Domínguez-Berrocal L, Zhang X, Zini JM, Fominaya J, Rebollo A, Bravo J.
PMID: 27152197
Biomark Res. 2016 May 04;4:9. doi: 10.1186/s40364-016-0063-6. eCollection 2016.

BACKGROUND: Disruption of alternative splicing in apoptotic factors has been associated to chronic lymphocytic leukemia among other cancers and hematological malignancies. The proapoptotic proteins Caspase-9 and PP2Acα are functionally related in a direct interaction, which constitutes a promising target...

Cite
Domínguez-Berrocal L, Zhang X, Zini JM, et al. Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia. Biomark Res. 2016;4:9doi: 10.1186/s40364-016-0063-6.
Domínguez-Berrocal, L., Zhang, X., Zini, J. M., Fominaya, J., Rebollo, A., & Bravo, J. (2016). Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia. Biomarker research, 49. https://doi.org/10.1186/s40364-016-0063-6
Domínguez-Berrocal, Leticia, et al. "Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia." Biomarker research vol. 4 (2016): 9. doi: https://doi.org/10.1186/s40364-016-0063-6
Domínguez-Berrocal L, Zhang X, Zini JM, Fominaya J, Rebollo A, Bravo J. Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia. Biomark Res. 2016 May 04;4:9. doi: 10.1186/s40364-016-0063-6. eCollection 2016. PMID: 27152197; PMCID: PMC4857392.
Copy Download .nbib Format: NLM
Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects.

Biomarker research

Tosi S, Mostafa Kamel Y, Owoka T, Federico C, Truong TH, Saccone S.
PMID: 26605042
Biomark Res. 2015 Oct 05;3:21. doi: 10.1186/s40364-015-0041-4. eCollection 2015.

The presence of chromosomal abnormalities is one of the most important criteria for leukaemia diagnosis and management. Infant leukaemia is a rare disease that affects children in their first year of life. It has been estimated that approximately one...

Cite
Tosi S, Mostafa Kamel Y, Owoka T, et al. Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects. Biomark Res. 2015;3:21doi: 10.1186/s40364-015-0041-4.
Tosi, S., Mostafa Kamel, Y., Owoka, T., Federico, C., Truong, T. H., & Saccone, S. (2015). Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects. Biomarker research, 321. https://doi.org/10.1186/s40364-015-0041-4
Tosi, Sabrina, et al. "Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects." Biomarker research vol. 3 (2015): 21. doi: https://doi.org/10.1186/s40364-015-0041-4
Tosi S, Mostafa Kamel Y, Owoka T, Federico C, Truong TH, Saccone S. Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects. Biomark Res. 2015 Oct 05;3:21. doi: 10.1186/s40364-015-0041-4. eCollection 2015. PMID: 26605042; PMCID: PMC4657620.
Copy Download .nbib Format: NLM
CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function.

Biomarker research

Thakar K, Novero A, Das A, Lisinschi A, Mehta B, Ahmed T, Liu D.
PMID: 24991411
Biomark Res. 2014 Jun 23;2:12. doi: 10.1186/2050-7771-2-12. eCollection 2014.

ABVD regimen (doxorubicin, bleomycin, vinblastine and dacarbazine) remains the most commonly used front-line therapy for Hodgkin lymphoma. However, atypical and extranodal presentations present challenges to initial therapy, especially in the presence of renal and liver failure. We hereby present...

Cite
Thakar K, Novero A, Das A, et al. CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function. Biomark Res. 2014;2:12doi: 10.1186/2050-7771-2-12.
Thakar, K., Novero, A., Das, A., Lisinschi, A., Mehta, B., Ahmed, T., & Liu, D. (2014). CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function. Biomarker research, 212. https://doi.org/10.1186/2050-7771-2-12
Thakar, Keyur, et al. "CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function." Biomarker research vol. 2 (2014): 12. doi: https://doi.org/10.1186/2050-7771-2-12
Thakar K, Novero A, Das A, Lisinschi A, Mehta B, Ahmed T, Liu D. CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function. Biomark Res. 2014 Jun 23;2:12. doi: 10.1186/2050-7771-2-12. eCollection 2014. PMID: 24991411; PMCID: PMC4078319.
Copy Download .nbib Format: NLM
Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model.

Biomarker research

Xu HN, Nioka S, Li LZ.
PMID: 24252270
Biomark Res. 2013 Jan 17;1(1):6. doi: 10.1186/2050-7771-1-6.

BACKGROUND: Metabolic alteration is one of the hallmarks of carcinogenesis. We aimed to identify certain metabolic biomarkers for the early detection of pancreatic cancer (PC) using the transgenic PTEN-null mouse model. Pancreas-specific deletion of PTEN in mouse caused progressive...

Cite
Xu HN, Nioka S, Li LZ. Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomark Res. 2013;1(1):6doi: 10.1186/2050-7771-1-6.
Xu, H. N., Nioka, S., & Li, L. Z. (2013). Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomarker research, 1(1), 6. https://doi.org/10.1186/2050-7771-1-6
Xu, He N, et al. "Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model." Biomarker research vol. 1,1 (2013): 6. doi: https://doi.org/10.1186/2050-7771-1-6
Xu HN, Nioka S, Li LZ. Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomark Res. 2013 Jan 17;1(1):6. doi: 10.1186/2050-7771-1-6. PMID: 24252270; PMCID: PMC3776248.
Copy Download .nbib Format: NLM
Integration of a bacterial gene sequence into a chronic eosinophilic leukemia patient's genome as part of a fusion gene linker.

Biomarker research

Sidhoo S, Rosales JL, Lee KY.
PMID: 28593047
Biomark Res. 2017 Jun 05;5:20. doi: 10.1186/s40364-017-0101-z. eCollection 2017.

Analysis of databases from the human genome project (HGP), the 1000 Genomes Project (1KGP), and The Cancer Genome Atlas (TCGA) revealed bacterial DNA integration into the human somatic genome, particularly in tumor tissues. Fusion genes have also been associated...

Cite
Sidhoo S, Rosales JL, Lee KY. Integration of a bacterial gene sequence into a chronic eosinophilic leukemia patient's genome as part of a fusion gene linker. Biomark Res. 2017;5:20doi: 10.1186/s40364-017-0101-z.
Sidhoo, S., Rosales, J. L., & Lee, K. Y. (2017). Integration of a bacterial gene sequence into a chronic eosinophilic leukemia patient's genome as part of a fusion gene linker. Biomarker research, 520. https://doi.org/10.1186/s40364-017-0101-z
Sidhoo, Saveen, et al. "Integration of a bacterial gene sequence into a chronic eosinophilic leukemia patient's genome as part of a fusion gene linker." Biomarker research vol. 5 (2017): 20. doi: https://doi.org/10.1186/s40364-017-0101-z
Sidhoo S, Rosales JL, Lee KY. Integration of a bacterial gene sequence into a chronic eosinophilic leukemia patient's genome as part of a fusion gene linker. Biomark Res. 2017 Jun 05;5:20. doi: 10.1186/s40364-017-0101-z. eCollection 2017. PMID: 28593047; PMCID: PMC5460404.
Copy Download .nbib Format: NLM
Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers.

Biomarker research

Calatayud D, Dehlendorff C, Boisen MK, Hasselby JP, Schultz NA, Werner J, Immervoll H, Molven A, Hansen CP, Johansen JS.
PMID: 28239461
Biomark Res. 2017 Feb 21;5:8. doi: 10.1186/s40364-017-0087-6. eCollection 2017.

BACKGROUND: The aim of this study was to validate previously described diagnostic and prognostic microRNA expression profiles in tissue samples from patients with pancreatic cancer and other periampullary cancers.METHODS: Expression of 46 selected microRNAs was studied in formalin-fixed paraffin-embedded...

Cite
Calatayud D, Dehlendorff C, Boisen MK, et al. Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers. Biomark Res. 2017;5:8doi: 10.1186/s40364-017-0087-6.
Calatayud, D., Dehlendorff, C., Boisen, M. K., Hasselby, J. P., Schultz, N. A., Werner, J., Immervoll, H., Molven, A., Hansen, C. P., & Johansen, J. S. (2017). Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers. Biomarker research, 58. https://doi.org/10.1186/s40364-017-0087-6
Calatayud, Dan, et al. "Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers." Biomarker research vol. 5 (2017): 8. doi: https://doi.org/10.1186/s40364-017-0087-6
Calatayud D, Dehlendorff C, Boisen MK, Hasselby JP, Schultz NA, Werner J, Immervoll H, Molven A, Hansen CP, Johansen JS. Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers. Biomark Res. 2017 Feb 21;5:8. doi: 10.1186/s40364-017-0087-6. eCollection 2017. PMID: 28239461; PMCID: PMC5320745.
Copy Download .nbib Format: NLM
A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia.

Biomarker research

Cavalcante Mde S, Torres-Romero JC, Lobo MD, Moreno FB, Bezerra LP, Lima DS, Matos JC, Moreira Rde A, Monteiro-Moreira AC.
PMID: 26823978
Biomark Res. 2016 Jan 27;4:1. doi: 10.1186/s40364-016-0055-6. eCollection 2016.

BACKGROUND: Acute lymphoblastic leukemia is the most common malignant cancer in childhood. The signs and symptoms of childhood cancer are difficult to recognize, as it is not the first diagnosis to be considered for nonspecific complaints, leading to potential...

Cite
Cavalcante Mde S, Torres-Romero JC, Lobo MD, et al. A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia. Biomark Res. 2016;4:1doi: 10.1186/s40364-016-0055-6.
Cavalcante, M. d. e. . S., Torres-Romero, J. C., Lobo, M. D., Moreno, F. B., Bezerra, L. P., Lima, D. S., Matos, J. C., Moreira, R. d. e. . A., & Monteiro-Moreira, A. C. (2016). A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia. Biomarker research, 41. https://doi.org/10.1186/s40364-016-0055-6
Cavalcante, Marcio de Souza, et al. "A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia." Biomarker research vol. 4 (2016): 1. doi: https://doi.org/10.1186/s40364-016-0055-6
Cavalcante Mde S, Torres-Romero JC, Lobo MD, Moreno FB, Bezerra LP, Lima DS, Matos JC, Moreira Rde A, Monteiro-Moreira AC. A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia. Biomark Res. 2016 Jan 27;4:1. doi: 10.1186/s40364-016-0055-6. eCollection 2016. PMID: 26823978; PMCID: PMC4730630.
Copy Download .nbib Format: NLM
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.

Biomarker research

Mangolini A, Ferracin M, Zanzi MV, Saccenti E, Ebnaof SO, Poma VV, Sanz JM, Passaro A, Pedriali M, Frassoldati A, Querzoli P, Sabbioni S, Carcoforo P, Hollingsworth A, Negrini M.
PMID: 26120471
Biomark Res. 2015 Jun 06;3:12. doi: 10.1186/s40364-015-0037-0. eCollection 2015.

BACKGROUND: Breast cancer circulating biomarkers include carcinoembryonic antigen and carbohydrate antigen 15-3, which are used for patient follow-up. Since sensitivity and specificity are low, novel and more useful biomarkers are needed. The presence of stable circulating microRNAs (miRNAs) in...

Cite
Mangolini A, Ferracin M, Zanzi MV, et al. Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR. Biomark Res. 2015;3:12doi: 10.1186/s40364-015-0037-0.
Mangolini, A., Ferracin, M., Zanzi, M. V., Saccenti, E., Ebnaof, S. O., Poma, V. V., Sanz, J. M., Passaro, A., Pedriali, M., Frassoldati, A., Querzoli, P., Sabbioni, S., Carcoforo, P., Hollingsworth, A., & Negrini, M. (2015). Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR. Biomarker research, 312. https://doi.org/10.1186/s40364-015-0037-0
Mangolini, Alessandra, et al. "Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR." Biomarker research vol. 3 (2015): 12. doi: https://doi.org/10.1186/s40364-015-0037-0
Mangolini A, Ferracin M, Zanzi MV, Saccenti E, Ebnaof SO, Poma VV, Sanz JM, Passaro A, Pedriali M, Frassoldati A, Querzoli P, Sabbioni S, Carcoforo P, Hollingsworth A, Negrini M. Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR. Biomark Res. 2015 Jun 06;3:12. doi: 10.1186/s40364-015-0037-0. eCollection 2015. PMID: 26120471; PMCID: PMC4483205.
Copy Download .nbib Format: NLM
Nuclear protein IK undergoes dynamic subcellular translocation and forms unique nuclear bodies during the cell cycle.

Biomarker research

Hu L, Yang F, Liu X, Xu D, Dai W.
PMID: 24252166
Biomark Res. 2013 Feb 18;1(1):11. doi: 10.1186/2050-7771-1-11.

IK is a nuclear protein containing a unique domain named RED due to the presence of a repetitive arginine (R), aspartic (E), and glutamic acid (D) sequence. To date, the function of this protein remains largely unknown despite of...

Cite
Hu L, Yang F, Liu X, et al. Nuclear protein IK undergoes dynamic subcellular translocation and forms unique nuclear bodies during the cell cycle. Biomark Res. 2013;1(1):11doi: 10.1186/2050-7771-1-11.
Hu, L., Yang, F., Liu, X., Xu, D., & Dai, W. (2013). Nuclear protein IK undergoes dynamic subcellular translocation and forms unique nuclear bodies during the cell cycle. Biomarker research, 1(1), 11. https://doi.org/10.1186/2050-7771-1-11
Hu, Liyan, et al. "Nuclear protein IK undergoes dynamic subcellular translocation and forms unique nuclear bodies during the cell cycle." Biomarker research vol. 1,1 (2013): 11. doi: https://doi.org/10.1186/2050-7771-1-11
Hu L, Yang F, Liu X, Xu D, Dai W. Nuclear protein IK undergoes dynamic subcellular translocation and forms unique nuclear bodies during the cell cycle. Biomark Res. 2013 Feb 18;1(1):11. doi: 10.1186/2050-7771-1-11. PMID: 24252166; PMCID: PMC4177551.
Copy Download .nbib Format: NLM
The emerging roles of Notch signaling in leukemia and stem cells.

Biomarker research

Liu N, Zhang J, Ji C.
PMID: 24252593
Biomark Res. 2013 Jul 18;1(1):23. doi: 10.1186/2050-7771-1-23.

The Notch signaling pathway plays a critical role in maintaining the balance between cell proliferation, differentiation and apoptosis, and is a highly conserved signaling pathway that regulates normal development in a context- and dose-dependent manner. Dysregulation of Notch signaling...

Cite
Liu N, Zhang J, Ji C. The emerging roles of Notch signaling in leukemia and stem cells. Biomark Res. 2013;1(1):23doi: 10.1186/2050-7771-1-23.
Liu, N., Zhang, J., & Ji, C. (2013). The emerging roles of Notch signaling in leukemia and stem cells. Biomarker research, 1(1), 23. https://doi.org/10.1186/2050-7771-1-23
Liu, Na, et al. "The emerging roles of Notch signaling in leukemia and stem cells." Biomarker research vol. 1,1 (2013): 23. doi: https://doi.org/10.1186/2050-7771-1-23
Liu N, Zhang J, Ji C. The emerging roles of Notch signaling in leukemia and stem cells. Biomark Res. 2013 Jul 18;1(1):23. doi: 10.1186/2050-7771-1-23. PMID: 24252593; PMCID: PMC4177577.
Copy Download .nbib Format: NLM
Metabolomic analyses for atherosclerosis, diabetes, and obesity.

Biomarker research

Du F, Virtue A, Wang H, Yang XF.
PMID: 24252331
Biomark Res. 2013 Apr 01;1(1):17. doi: 10.1186/2050-7771-1-17.

Insulin resistance associated with type 2 diabetes mellitus (T2DM), obesity, and atherosclerosis is a global health problem. A portfolio of abnormalities of metabolic and vascular homeostasis accompanies T2DM and obesity, which are believed to conspire to lead to accelerated...

Cite
Du F, Virtue A, Wang H, et al. Metabolomic analyses for atherosclerosis, diabetes, and obesity. Biomark Res. 2013;1(1):17doi: 10.1186/2050-7771-1-17.
Du, F., Virtue, A., Wang, H., & Yang, X. F. (2013). Metabolomic analyses for atherosclerosis, diabetes, and obesity. Biomarker research, 1(1), 17. https://doi.org/10.1186/2050-7771-1-17
Du, Fuyong, et al. "Metabolomic analyses for atherosclerosis, diabetes, and obesity." Biomarker research vol. 1,1 (2013): 17. doi: https://doi.org/10.1186/2050-7771-1-17
Du F, Virtue A, Wang H, Yang XF. Metabolomic analyses for atherosclerosis, diabetes, and obesity. Biomark Res. 2013 Apr 01;1(1):17. doi: 10.1186/2050-7771-1-17. PMID: 24252331; PMCID: PMC4177614.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 389 entries